biote Corp.
BTMDNasdaqCIK 1819253HealthcareFiscal year ends Dec 31
Reports and events: 108 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0716:30 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-340364 |
| 2026-08-0516:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-335200 |
| 2026-06-1716:05 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001193125-26-274137 |
| 2026-06-0217:17 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-253858 |
| 2026-05-1816:30 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-229013 |
| 2026-05-1116:11 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-216780 |
| 2026-05-0616:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-208965 |
| 2026-04-0316:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-142147 |
| 2026-04-0216:10 ET | DEF 14A | Proxy statementPeriod 2026-05-12 | 0001193125-26-140096 |
| 2026-03-1316:04 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-106099 |
| 2026-03-1116:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-102129 |
| 2026-01-2617:21 ET | 8-K | 8.01 Other events | 0001193125-26-022818 |
| 2025-11-0716:05 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-272294 |
| 2025-11-0516:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-266910 |
| 2025-08-0816:01 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-105800 |
| 2025-08-0616:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-104014 |
| 2025-06-1221:17 ET | SCHEDULE 13D | Ownership report, active investor | 0000919574-25-003576 |
| 2025-06-0916:40 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-137873 |
| 2025-06-0508:22 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-135341 |
| 2025-05-1416:15 ET | 8-K | 5.07 Shareholder vote results | 0001193125-25-119861 |
| 2025-05-0916:21 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-068059 |
| 2025-05-0716:06 ET | 8-K | 2.02 Results of operations; 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits | 0000950170-25-065638 |
| 2025-04-2416:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-093531 |
| 2025-04-0316:53 ET | DEF 14A | Proxy statementPeriod 2025-05-13 | 0001193125-25-072431 |
| 2025-03-1708:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-055224 |
| 2025-03-1416:04 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-039394 |
| 2025-03-1216:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-052946 |
| 2025-01-3016:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-017314 |
| 2024-11-1217:16 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-125678 |
| 2024-11-1216:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-255973 |
| 2024-08-0913:52 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-094529 |
| 2024-08-0816:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-196974 |
| 2024-07-0516:05 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-24-175600 |
| 2024-07-0316:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-175041 |
| 2024-06-2120:31 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-164885 |
| 2024-05-2407:30 ET | 8-K | 5.07 Shareholder vote results | 0001193125-24-146528 |
| 2024-05-1015:05 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-057713 |
| 2024-05-0716:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-133133 |
| 2024-04-2916:24 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-122394 |
| 2024-04-1116:16 ET | DEF 14A | Proxy statementPeriod 2024-05-21 | 0001193125-24-093250 |
| 2024-03-1514:52 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-032101 |
| 2024-03-1416:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-067887 |
| 2024-03-1216:43 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-065961 |
| 2024-02-2016:19 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-040005 |
| 2024-01-2516:33 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-015456 |
| 2024-01-1716:39 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-009293 |
| 2024-01-1116:37 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-006634 |
| 2023-11-1316:30 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-063027 |
| 2023-11-0717:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-272557 |
| 2023-08-1115:09 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-041796 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.